StreetAlpha.app
Home › Stocks › ADMA

Adma Biologics, Inc. (ADMA)

Healthcare
$13.63
▲ +1.19%
LAST CLOSE · NOV 17

ADMA Biologics makes immune globulin treatments from human blood plasma for patients with weakened immune systems. It last closed at $13.63 on Nov 17, up 1.19% on the day. In the past 30 days there were 1 dark pool print totaling $1.6M, the largest $1.6M.

AI Auto Pilots
Is ADMA in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$519.2M
+6.3% vs a year ago
Net income
$182.4M
−12.9% vs a year ago
EPS (diluted)
$0.77
−10.5% vs a year ago
Free cash flow
$132.9M
25.6% margin
Valuation
Market cap
$3.0B
221.9M shares
P/E
17.7
Price over 12 month EPS
Price to sales
5.8
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$124.6M
At Sep 30
Debt
$195.9M
At Sep 30
Shareholder equity
$438.5M
Buybacks
$189.2M
Last 12 months
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $80.9M$80.9MFY2021FY2022: $154.1M$154.1MFY2022FY2023: $258.2M$258.2MFY2023FY2024: $426.5M$426.5MFY2024FY2025: $510.2M$510.2MFY2025

From ADMA's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Next report
—
No date on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
1 Hold
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Hold
1firm
0 Buy1 Hold0 Sell
Only 1 firm rated ADMA in the past 90 days, not enough for a consensus
Average 12-month target
$13.00
▼ 4.6% downside

Based on 1 analyst who set a price target on ADMA in the past 90 days. The average target is $13.00, with a high of $13.00 and a low of $13.00, compared with the last close of $13.63.

Low $13.00Avg $13.00High $13.00
Blue marker: last close $13.63
Highest target$13.00
Average target$13.00
Lowest target$13.00
Latest rating changes
Cantor FitzgeraldMaintained
Nov 5Hold$13
MizuhoMaintained
Jul 15Buy$17
Canaccord GenuityInitiated
Apr 21Buy$21
DateFirmActionRatingPrice target
Nov 5Cantor FitzgeraldMaintainedHold$13
Jul 15MizuhoMaintainedBuy$17
Apr 21Canaccord GenuityInitiatedBuy$21
Loading…

Technical Analysis

ADMA · as of the Nov 17 close · updated after every close
Uptrend, nearing overbought

The stock is 12% above its 20 day and 21% above its 50 day average. It is 22% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 69), near overbought. The nearest support is the Pivot at $13.47, and the nearest resistance the Pivot R1 at $13.81.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityHigh, 4.6%/day
Key levels
$20.4652 week high+50.1%
$13.81Pivot R1+1.3%
$13.63Last close
$13.47Pivot−1.2%
$13.28Pivot S1−2.6%
$12.0320 day average−11.7%
$10.7350 day average−21.3%
$10.69200 day average−21.6%
$10.57Swing low (Oct 23)−22.5%
$9.95100 day average−27.0%
$7.2152 week low−47.1%
Indicators
RSI (14)69.13Strong, overbought above 70Neutral
MACD0.82Above its signal lineBullish
Stochastic88.0Near the top of its rangeOverbought
ADX (14)35.2Trending up
Williams %R-11.3Oversold below −80, overbought above −20Overbought
CCI (20)96.8Oversold below −100, overbought above 100Neutral
Rate of change+22.7%Change over 10 sessionsBullish
ATR (14)$0.63Typical daily range, 4.6% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for ADMA

What happened before

See how ADMA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow ADMA usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How ADMA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2013.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in ADMA in the last 90 days.

Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
1
Notional
$1.6M
Largest print
$1.6M
Loading…

ADMA Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●151 buying vs 154 selling
  • ▼Held by funds -2.6 pts
  • ▲Funds holding +6
  • ▼Superinvestors: 2 added, 4 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding329323+1.9%
In funds' top 10330.0%
Held by funds90.5%93.1%−2.6 pts
New / increased40 / 11148 / 91+8.6%
Reduced / sold out120 / 34147 / 87−34.2%
Put/call ratio0.530.48+9.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ADMA institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ADMA is in one of them and how their past ADMA trades turned out.

ADMA in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ADMA in an article yet. Here's the latest on the wider market.

ADMA Congress Trades

All congress trades →
Trades, 12 months
5
Buys
2
40%
Sells
2
40%
People
1
Last filed Sep 22
Who traded ADMA · since 2026
Latest 5 filings
$1K – $15KTraded Jul 29, 2026Filed Sep 22, 2026
$15K – $50KTraded May 15, 2026Filed Jul 1, 2026
$15K – $50KTraded Mar 4, 2026Filed May 14, 2026
$15K – $50KTraded Feb 26, 2026Filed May 14, 2026
$15K – $50KTraded Jan 26, 2026Filed May 14, 2026
PersonTypeAmountTradedFiledDelay
Donald J TrumpExecutive branchSell$1K – $15KJul 29, 2026Sep 22, 202655 d
Donald J TrumpExecutive branchSell$15K – $50KMay 15, 2026Jul 1, 202647 d
Donald J TrumpExecutive branchBuy$15K – $50KMar 4, 2026May 14, 202671 d
Donald J TrumpExecutive branchBuy$15K – $50KFeb 26, 2026May 14, 202677 d
Donald J TrumpExecutive branchOther$15K – $50KJan 26, 2026May 14, 2026108 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Adma Biologics

ADMA Biologics is a biopharmaceutical company based in Ramsey, New Jersey. It makes specialty biologics from human blood plasma for people with weakened immune systems and for people at risk of certain infectious diseases. Its main products are ASCENIV and BIVIGAM, two immune globulin treatments for primary immunodeficiency, and Nabi-HB, which is used after exposure to hepatitis B. The company also operates plasma collection centers, sells some plasma to other manufacturers, and its products are mainly used by physician specialists.

Headquarters
Ramsey, NJ